Proton magnetic resonance spectroscopy of plasma from patients with dyslipoproteinemia: identification of factors governing methyl and methylene proton line widths.
The line width of the proton magnetic resonance spectrum (MRS) of the composite methylene and methyl resonances of plasma has been reported as a marker for the presence of malignancy. In this study, the contribution of very low density (VLDL), low density (LDL), and high density lipoproteins (HDL) t...
Main Authors: | F G Herring, P S Phillips, P H Pritchard |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
1989-04-01
|
Series: | Journal of Lipid Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227520383413 |
Similar Items
-
Dyslipoproteinemia in renal transplantation.
by: Gunjotikar R, et al.
Published: (1994-01-01) -
Solvent effects in proton magnetic resonance spectroscopy
by: Wilson, R. G.
Published: (1969) -
Dyslipoproteinemia in Gestosis in Early Puerperium
by: L. N. Shcherbakova, et al.
Published: (2008-10-01) -
Proton Magnetic Resonance Spectroscopy-studies of Hydrogen Bonding of Iodoform with Several Proton Acceptors
by: Chen, Ching-Kaung, et al.
Published: (1974) -
Proton magnetic resonance spectroscopy of lung cancer in vivo
by: Sakae Fujimoto, MD, et al.
Published: (2020-07-01)